The FDA announced that it would strengthen its oversight for companies marketing the COVID-19 serology tests. After questions came to light in regards to the accuracy of some of the testing kits, the FDA is now requiring commercial manufacturers to submit an emergency use authorization (EUA) with validation data in order to continue their marketing. These manufacturers must submit an EUA with the validation data within 10 business days, and will disclose to the public the names of companies that fail to do so. 

Read more here

More on: